Esomeprazole and omeprazole could possibly improve the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in enhanced adverse effects including drowsiness, although the medical relevance is very low for most people – monitor the affected person for adverse effects (e. The objective of this study was To judge the anxiolytic, https://medeusresearchchem.com/product-category/research-chemicals/